(E,Z)-3-(3′,5′-Dimethoxy-4′-hydroxy-benzylidene)-2-indolinone blocks mast cell degranulation

被引:16
作者
Kiefer, S. [1 ]
Mertz, A. C. [2 ]
Koryakina, A. [1 ]
Hamburger, M. [1 ]
Kueenzi, P. [1 ]
机构
[1] Univ Basel, Inst Pharmaceut Biol, CH-4056 Basel, Switzerland
[2] Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4058 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Isatis tinctoria; Woad; Degranulation; Granule exocitosis; Indolinone; Mast cells; ISATIS-TINCTORIA; INHIBITORY-ACTIVITY; IN-VIVO; ACTIVATION; EXTRACTS; RECEPTOR; INDOLIN-2-ONES; TRYPTANTHRIN; DERIVATIVES; IGE;
D O I
10.1016/j.ejps.2010.03.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
(E,Z)-3-(3',5'-Dimethoxy-4'-hydroxy-benzylidene)-2-indolinone (indolinone) is an alkaloid that has been identified as a pharmacologically active compound in extracts of the traditional anti-inflammatory herb Isatis tinctoria. Indolinone has been shown to inhibit compound 48/80-induced mast cell degranulation in vitro. Application of indolinone to bone marrow derived mast cells showed that it was uniformly distributed in the cytoplasm and that cellular uptake was terminated within minutes. Pre-treatment of IgE-sensitized mast cells with 100 nM indolinone rendered them insensitive against Fc epsilon RI-receptor dependent degranulation. However, upstream signalling induced by antigen such as activation of PI3-K and MAPK remained unaffected. We conclude that indolinone blocks mast cell degranulation at the level of granule exocitosis with an IC50 of 54 nm. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 33 条
[1]   Sunitinib maleate [J].
Atkins, M ;
Jones, CA ;
Kirkpatrick, P .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :279-280
[2]   Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-ones [J].
Boechat, Nubia ;
Kover, W. Bruce ;
Bongertz, Vera ;
Bastos, Monica M. ;
Romeiro, Nelilma C. ;
Azevedo, Maria L. G. ;
Wollinger, Wagner .
MEDICINAL CHEMISTRY, 2007, 3 (06) :533-542
[3]   Synthesis and biological evaluation of diversely substituted indolin-2-ones [J].
Bouchikhi, Fadoua ;
Rossignol, Emilie ;
Sancelme, Martine ;
Aboab, Bettina ;
Anizon, Fabrice ;
Fabbro, Doriano ;
Prudhomme, Michelle ;
Moreau, Pascale .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (11) :2316-2322
[4]   Indolin-2-ones with high in vivo efficacy in a model for multiple sclerosis [J].
Bouérat, L ;
Fensholdt, J ;
Liang, XF ;
Havez, S ;
Nielsen, SF ;
Hansen, JR ;
Bolvig, S ;
Andersson, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5412-5414
[5]   Secretory granule exocytosis [J].
Burgoyne, RD ;
Morgan, A .
PHYSIOLOGICAL REVIEWS, 2003, 83 (02) :581-632
[6]   Anti-IgE as a mast cell-stabilizing therapeutic agent [J].
Chang, TW ;
Shiung, YY .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (06) :1203-1212
[7]   Nedocromil sodium: a review of the evidence for a dual mechanism of action [J].
Corin, RE .
CLINICAL AND EXPERIMENTAL ALLERGY, 2000, 30 (04) :461-468
[8]   Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria [J].
Danz, H ;
Stoyanova, S ;
Wippich, P ;
Brattström, A ;
Hamburger, M .
PLANTA MEDICA, 2001, 67 (05) :411-416
[9]  
DANZ H, 2000, THESIS F SCHILLER U
[10]   Omalizumab reverses the phenotypic and functional effects of IgE-Enhanced FcεRI on human skin mast cells [J].
Gomez, Gregorio ;
Jogie-Brahim, Sherryline ;
Shima, Mika ;
Schwartz, Lawrence B. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (02) :1353-1361